Mitochondrial Dysfunction in Neurodegenerative Disorders (2^nd Ed., 2nd ed. 2016)

This second edition brings together up-to-date contributions from leaders in the field internationally on the various ways in which mitochondrial dysfunction contributes to the pathogenesis of neurodegenerative diseases, including Parkinson?s disease, Alzheimer?s disease and multiple sclerosis. The reader is guided through the basic functions of mitochondria and the mechanisms that lead to their dysfunction, and on to the consequences of this dysfunction for neuronal function before finishing with the modelling of these disorders and discussion of new potential therapeutic targets. 

Additional chapters have been added to the book to reflect advances in the field and there are many new contributors and topics, including how mitochondria are degraded and the interaction of the mitochondria with pathologically relevant proteins. 

Mitochondrial Dysfunction in Neurodegenerative Disordersprovides an accessible, authoritative guide to this important area for neurologists; research and clinical neuroscientists; neuropathologists; and residents with an interest in clinical research.

Part I. Mitochondria and Neurodegenerative Disease.- An Introduction to Mitochondria, Their Structure and Functions.- Part II. Mitochondrial Dysfunction: Causes and Effects?.- Neurodegeneration in Mitochondrial Disorders.- The Ageing Brain, Mitochondria and Neurodegeneration.- Mitochondrial Genes and Neurodegenerative Disease.- Mitochondrial Signalling and Neurodegeneration.- Part III. Functional Consequences of Mitochondrial Dysfunction.- Life on the Edge: Determinants of Selective Neuronal Vulnerability in Parkinson’s Disease.- Mitochondrial Dynamics and Neurodegeneration.- Mitochondrial Dysfunction and Transport in Demyelinating Disease with Inflammation.- Mitochondria, the Synapse, and Neurodegeneration.- Protein Misfolding and Aggregation: Implications for Mitochondrial Dysfunction and Neurodegeneration.- Mitochondrial Degradation, Autophagy and Neurodegenerative Disease.- The Deleterious Duo of Neurodegeneration: Lysosomes and Mitochondria.- Part IV. Measuring the Contribution of Mitochondrial Dysfunction to Neurodegenerative Disease.- Can We Accurately Model Mitochondrial Dysfunction in Neurodegeneration?.- Mitochondrial Function and Dynamics Imaged In Vivo.-Part V.  The Future.- Development of Treatments and Therapies to Target Mitochondrial Dysfunction.- Summary and Conclusions.

Amy K. Reeve

Amy did her undergraduate degree in Neuroscience at Edinburgh University before moving to the Mitochondrial Research Group at Newcastle University for her PhD studies. She completed her PhD in the study of the molecular mechanisms of neurodegenerative disease in 2007 and now has her own research group within the Wellcome Trust Centre for Mitochondrial Research. Her current research interests centre around understanding the mechanisms behind the neurodegeneration seen in Parkinson’s disease, and the contribution of mitochondrial dysfunction to these changes. Funded by Parkinson’s UK as a research fellow Amy’s interests lie in understanding how changes within mitochondria, mitochondrial transport and the interaction of mitochondrial with alpha-synuclein contributes to the development of Parkinson’s disease.

Eve M. Simcox

Eve did her undergraduate degree in Biomedical Science at Newcastle University and continued her studies within the Mitochondrial Research Group for her PhD. She completed her PhD in the study of the turnover and dynamics of mitochondria in neurodegenerative disease in 2014 and now works as the impact officer for the faculty of Science, Agriculture and Engineering.

Michael R. Duchen

Discusses current research in a concise and logical format

Explains concepts using schematic diagrams, images and tables

Covers all aspects of the potential contribution of mitochondria

to neurodegenerative diseases, from the simple to the more complex, both in

terms of experimental data and literature review